# EDGAR Filing Document

**Accession Number:** 0001069530
**File Stem:** 0001493152-25-025914
**Filing Date:** 2025-12
**Character Count:** 2529
**Document Hash:** 30ac5cb965c7a219f6d26e2370cae93f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-025914.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001493152-25-025914

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251203

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CASSAVA SCIENCES INC
- **CENTRAL INDEX KEY:** 0001069530
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 911911336
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 6801 N CAPITAL OF TEXAS HIGHWAY
- **STREET 2:** BUILDING 1; SUITE 300
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78731
- **BUSINESS PHONE:** 512-501-2444

**MAIL ADDRESS:**
- **STREET 1:** 6801 N CAPITAL OF TEXAS HIGHWAY
- **STREET 2:** BUILDING 1; SUITE 300
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78731

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CASSAVA SCIENCES INC
- **DATE OF NAME CHANGE:** 20190326

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PAIN THERAPEUTICS INC
- **DATE OF NAME CHANGE:** 20000309

**CASSAVA SCIENCES, INC.**

**6801 N. Capital of Texas, Building 1**

**Suite 300**

**Austin, TX 78731**

December 3, 2025

**<u>Via EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, NE

Washington, DC 20549

Attn: Jessica Dickerson

Re: <u>Cassava Sciences, Inc. Registration Statement No. 333-291489</u>

Ladies and Gentlemen:

On behalf of Cassava Sciences, Inc. (the "<u>Company</u>"), the undersigned hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, that the effective time of the Registration Statement on Form S-3 (File No. 333-291489) filed on November 13, 2025 (the "<u>Registration Statement</u>") be accelerated to 4:15 p.m., New York City time, on Friday, December 5, 2025, or as soon as practicable thereafter. The Company respectfully requests that you notify Peter E. Devlin of such effectiveness by a telephone call to (212) 326-3978.

Should you have any questions regarding the Registration Statement, please contact Peter E. Devlin at (212) 326-3978.

Thank you for your attention to this matter.

---

| | |
|:---|:---|
| Sincerely, | Sincerely, |
| CASSAVA SCIENCES, INC. | CASSAVA SCIENCES, INC. |
| By: | */s/ Richard J. Barry* |
| Name: | Richard J. Barry |
| Title: | President and Chief Executive Officer |

---

cc: Peter E. Devlin <br> Ferrell M. Keel <br> Jones Day